Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Fig. 1.136 Fibromatosis. Fascicles of spindle myofibroblast invade the adipose tissue and extend between<br />
lobules (on the left).<br />
cells are absent. Variations include the<br />
o c c u r rence of infiltrating margins, a<br />
p rominent epithelioid cell component,<br />
mono- or multinucleated giant cells with<br />
a mild to severe degree of nuclear pleomorphism<br />
and extensive myxoid or hyaline<br />
change in the stroma. Occasionally,<br />
lipomatous, smooth muscle, cart i l a g i-<br />
nous or osseous components form additional<br />
integral parts of the tumour {934,<br />
1734-1736}. MFB should be distinguished<br />
from nodular fasciitis, inflammatory<br />
myofibroblastic tumour, fibromatosis,<br />
benign peripheral nerve sheath tumours,<br />
haemangiopericytomas and leiomyomas<br />
{1736}. The differential diagnosis is<br />
based on immunophenotype but even so<br />
may be difficult in some cases.<br />
Immunoprofile<br />
The neoplastic cells react positively for<br />
vimentin, desmin, α-smooth muscle actin<br />
and variably for CD34, bcl-2 protein,<br />
CD99 and sex steroid hormone receptors<br />
(estrogen, progesterone and androgen<br />
receptors) {1023,1733,1913}.<br />
Fibromatosis<br />
Definition<br />
This uncommon, locally aggre s s i v e ,<br />
lesion without metastatic potential originates<br />
from fibroblasts and myofibroblasts<br />
within the <strong>breast</strong> pare n c h y m a ,<br />
excluding mammary involvement by<br />
extension of a fibromatosis arising from<br />
the pectoral fascia.<br />
ICD-O code 8821/1<br />
Synonym<br />
Desmoid tumour.<br />
Epidemiology<br />
Fibromatosis accounts for less than 0.2%<br />
of all <strong>breast</strong> lesions {390,681,1083,<br />
2432,3063}. It is seen in women from 13<br />
to 80 years (average 46 and median 40)<br />
and is more common in the childbearing<br />
age than in perimenopausal or postmenopausal<br />
patients {681}. A few cases<br />
have been reported in men {378,2482}.<br />
Clinical features<br />
The lesion presents as a solitary, painless,<br />
firm or hard palpable mass. Bilateral<br />
tumours are rare {681,2432,3063}. Skin or<br />
nipple retraction may be observed {294}<br />
and rarely nipple discharge {3063}.<br />
M a m m o g r a p h i c a l l y, fibromatosis is indistinguishable<br />
from a <strong>carcinoma</strong> {681}.<br />
M a c r o s c o p y<br />
The poorly demarcated tumour measure s<br />
f rom 0.5 to 10 cm (average 2.5 cm)<br />
{681,2432,3063} with a firm, white-gre y<br />
cut surface.<br />
Histopathology<br />
M a m m a ry fibromatoses are histologically<br />
similar to those arising from the fascia or<br />
a p o n e u roses of muscles elsewhere in the<br />
body with the same immunophenotype.<br />
P roliferating spindled fibroblasts and<br />
m y o f i b roblasts form sweeping and interlacing<br />
fascicles; the periphery of the<br />
lesion reveals characteristic infiltrating fing<br />
e r-like projections entrapping mammary<br />
ducts and lobules {3063}.<br />
F i b romatosis must be distinguished fro m<br />
several entities in the bre a s t .<br />
F i b ro s a rcomas are richly cellular, with<br />
nuclear atypia and a much higher mitotic<br />
rate than fibromatosis. Spindle cell carc i-<br />
nomas disclose more typical areas of <strong>carcinoma</strong><br />
and, in contrast to fibro m a t o s i s ,<br />
the cells are immunoreactive for both<br />
epithelial markers and vimentin {1022}.<br />
Myoepithelial <strong>carcinoma</strong>s are actin and/or<br />
S-100 protein positive. While CAM 5.2<br />
positivity may be weak, pancytokeratin<br />
( K e rmix) is strongly expressed in at least<br />
some tumour cells, and there is diff u s e<br />
staining with CK34Beta E12 and CK 5,6.<br />
Lipomatous myofibroblastomas show a<br />
f i n g e r-like infiltrating growth pattern, re m i-<br />
niscent of fibromatosis {1736}. However,<br />
the cells are estrogen (ER), pro g e s t e ro n e<br />
(PR) and androgen receptor (AR) positive<br />
in 70% of cases, while fibromatosis does<br />
not stain with these antibodies.<br />
Nodular fasciitis is also composed of<br />
i m m a t u re appearing fibroblasts but tends<br />
to be more circumscribed, and has a<br />
higher mitotic rate. The prominent inflamm<br />
a t o ry infiltrate is scattered thro u g h o u t<br />
the lesion and is not limited to the perip<br />
h e ry as in fibro m a t o s i s .<br />
Reactive spindle cell nodules and scars<br />
a t the site of a prior trauma or surgery demonstrate<br />
areas of fat necrosis, calcifications<br />
and foreign body granulomas, feat<br />
u res that are not common in fibromatosis.<br />
I m m u n o p ro f i l e<br />
The spindle cells are vimentin positive<br />
and a small pro p o rtion of them are also<br />
actin positive, while they are invariably<br />
negative for cytokeratin and S-100 protein.<br />
In contrast to one-third of extram<br />
a m m a ry desmoid tumours {1662,1888,<br />
2353}, fibromatoses in the <strong>breast</strong> are ER,<br />
PR, AR, and pS2 (assessed as a measure<br />
of functional ER) negative {681,2335}.<br />
Prognosis and predictive factors<br />
M a m m a ry fibromatoses display a low<br />
p ropensity for local re c u r rence, with a<br />
re p o rted frequency of 21% {1083}, 23%<br />
{3063}, and 27% {2432} of cases comp<br />
a red with that of 57% {790} for extram<br />
a m m a ry lesions. When it does occur,<br />
one or more generally develop within two<br />
to three years of initial surgery {1083,<br />
3063}, but local re c u r rence may develop<br />
after a 6-year interval {3063}.<br />
92 Tumours of the <strong>breast</strong>